MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions

Volume: 71, Issue: 12, Pages: 814 - 822
Published: Oct 1, 2021
Abstract
The genetic alterations in the recurrent breast fibroepithelial tumors are poorly understood. In the present study, we aimed to investigate mediator protein complex subunit 12 (MED12) exon 2 and telomerase reverse transcriptase (TERT) promoter mutations in a series of primary and recurrent fibroepithelial tumors. Sanger sequencing for MED12 exon 2 and TERT promoter was performed in 26 pairs of primary and recurrent fibroepithelial tumors (19...
Paper Details
Title
MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions
Published Date
Oct 1, 2021
Volume
71
Issue
12
Pages
814 - 822
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.